Background
Introduction
Today, surgical aortic valve replacement (SAVR) is the standard treatment for patients with operable severe aortic stenosis (AS) (1, 2). Surgical treatment for AS improves survival and enhances patients' quality of life (3) (4) (5) . In older patients (>75 years) with symptomatic severe AS and who are at high surgical risk, transcatheter aortic valve replacement (TAVR) is the established alternative to SAVR (1, 6, 7). TAVR yields favorable outcomes compared to medical treatment (8) .
Arrhythmias, infections, or other complications after SAVR and TAVR are relatively frequent (9) and often require readmission to the hospital. Unplanned readmissions are costly for individuals and the public and negatively affect patients' quality of life and rehabilitation (10) . Furthermore, it increases the risk for hospital-acquired complications (10) . In the literature, it is reported that the incidence of 30-day all-cause readmissions after SAVR and TAVR is about one out of every four discharges results in a readmission (9, 11, 12) .
However, reported readmission rates vary substantially. Hence, the precise estimation of the magnitude of the problem remains unaddressed. Moreover, risk factors for and causes of readmissions following SAVR and TAVR have not yet been systematically scrutinized. This information is important, because it can guide clinicians, hospital administrators, and policymakers in developing and implementing programs to improve the quality of care for SAVR and TAVR patients following hospital discharge. This will be even more important in the coming years, as the increasing trend in life expectancy translates to more SAVR and TAVR procedures (5, (13) (14) (15) ). An accurate estimation of readmission rates and risk factors leading up to them is also relevant for researchers in the area of valve replacement, because resulting data could be used for benchmarking and would enable researchers to calculate the sample sizes needed for future trials that assess interventions to reduce readmissions.
These issues prompted us to conduct a systematic literature review and meta-analysis.
Our aims were (i) to estimate the overall 30-day all-cause readmission rate in patients following SAVR and TAVR, and (ii) to identify risk factors for and causes of 30-day allcause readmissions after discharge of these patients.
Methods
The protocol for this systematic literature review and meta-analysis was prospectively registered in the International Prospective Register of Systematic Reviews (PROSPERO; no.
42016032670). The Preferred Reporting Items for Systematic reviews and Meta-analysis (PRISMA) guidelines were used. (16).

Literature search
The first author (SOD) developed the search strategy in collaboration with an experienced research librarian. The following databases were consulted: Cochrane (Cochrane database of Systematic Reviews, Cochrane Central Register of Controlled Trials, Cochrane Methodology Register, NHS Economic Evaluation Database, Health Technology Assessment Database and Other Reviews); Medline (accessed through PubMed; http://www.ncbi.nlm.nih.gov/pubmed); Embase; UpToDate; PROSPERO; National Guideline Clearinghouse; SveMed; and Oria.no.
In addition, reference lists of candidate articles were screened to find additional references missed by our search strings (i.e., snowball method). Details on the search terms and the search strings can be found in online Table 2 . Publication date limits were set from database inception to October 8, 2017 . Language search was limited to English, and the Scandinavian languages. If necessary information was missing, we emailed the authors to obtain additional information.
Articles were eligible for inclusion if they reported study results on 30-day all-cause readmission following SAVR and TAVR procedures. For the present review, we defined 30-day all-cause readmission as an unplanned readmission for any reason within 30 days after discharge (17). We excluded articles that reported results from studies dealing with multiple valves or specific diseases/conditions related to the SAVR and TAVR treatment. We also excluded articles that reported results from studies dealing with procedural or cardiac-related causes or other specific causes for readmissions, because they did not address all-cause readmissions. One researcher (SOD) screened all the records identified by title, and two researchers (SOD/IL) assessed the full-text candidate articles of the first screening using the inclusion criteria listed above. Before our review was completed, we consulted the databases several more times to check whether we had missed any eligible articles (Online Table 2 ).
Data abstraction
Data from included articles were extracted onto a standard form according to an a priori protocol. Extracted data included information on study-related characteristics, patient-related characteristics, and main findings. The study-related variables included the article's year of publication; country where the study took place; representativeness of the cohort (singlecenter, multicenter, or nationwide data); whether the cohort was prospectively or retrospectively studied; and whether 30-day all-cause readmission was reported as a primary or secondary endpoint. Patient-related variables included mean age and proportion of the study population that were males. The results we were interested in, and what we extracted, pertained to the total sample size reported in the article and the number of events (30-day allcause readmission).
Quality of the studies
Two researchers independently assessed the quality of the studies (SOD/IL) using the Newcastle-Ottawa Scale (NOS). NOS is an established scale for assessment of cohort studies (18). For studies with no relevant data accordingly to NOS items for appraisal, we noted them as "not relevant" (NR). Consensus by discourse resolved disagreements.
Statistical analysis
To calculate an overall incidence of 30-day all-cause readmission, we used a random effects meta-analysis of single proportions according to the DerSimonian-Laird method (19). We used the Freeman-Turkey double arcsine transformation to stabilize the variance (20).
Heterogeneity between studies was assessed with the Cochran's Q test, and its magnitude was evaluated by the I 2 statistic. This describes the proportion of total variation due to heterogeneity rather than chance (21 
Results
Included articles
One article was excluded because it reported results from another article we had already included. Another article was excluded because the mean age of participants in the study was >80 years. We identified a total of 6867 candidate articles (Fig.1) . After duplicates were removed, we reviewed the title and abstract of 6848 articles, 6588 of which were not relevant for our purposes. The remaining 260 articles were assessed for eligibility based on full-text review; 227 were deemed ineligible. We included 33 articles in the systematic review and 32 in the meta-analysis, 12 on the SAVR population and 20 on the TAVR population.
Study characteristics in included articles
The characteristics of the studies included are presented in Online 
Quality assessment and publication bias
The overall quality of studies in the included articles was moderate on the NOS. Many of these retrospective studies failed to provide descriptions of how the outcome was derived and how it was validated. Thus, this produced an overall assessment of moderate quality (online Table 3 ). We found no publication bias, neither in SAVR studies (Egger test, p=0.255) nor in TAVR studies (Egger test, p=0.140). Funnel plots are presented in online material (Online Fig. 1 ).
Incidence of 30-day all-cause readmission rate following SAVR or TAVR
The incidence of 30-day all-cause readmission rate for SAVR ranged from 7-23%, and for TAVR, from 5-27%. The pooled estimated proportion of the 30-day all-cause readmission after SAVR was 17% (95% CI: 16-18), with substantial heterogeneity (I 2 =98.44%) (Fig. 2 ).
Subgroup analysis of heterogeneity in the SAVR population revealed a significantly higher readmission rate in multicenter studies (20%) compared to single-center studies (12%) ( Table   1 ). Regional differences were also observed, with higher readmission rates in the USA (18%) compared to other countries (14%). A lower incidence of readmissions was found in prospective (14%) compared to retrospective (17%) studies. We also found a difference in studies reporting on readmission as a primary (17%) versus secondary (15%) endpoint (Table   1 ).
The pooled estimated proportion of the 30-day all-cause readmission after TAVR was 16% (95% CI: 15-18), also with substantial heterogeneity (I 2 =97.06%) (Fig. 2 ). Subgroup analysis revealed more readmissions in multicenter studies (18%) compared to single-center studies (12%) ( Table 1 ). Regional differences were observed, with a higher incidence in the USA (18%) compared to other countries (14%). A lower incidence was found in prospective (11%) studies compared to retrospective (17%) studies.
We also extended the analyses by using a random effect meta-regression model in the univariable mode. With this approach, we found that the only study-level variable significantly associated with readmission rate was single-center studies versus multicenter studies ( Table 2) . Sixty-nine percent of between-study heterogeneity was accounted for by this study-level variable in the SAVR population (p=0.013), and 24% in the TAVR population (p=0.038). Furthermore, USA versus other countries was marginally associated with readmission in the TAVR population (p=0.091).
In the meta-analysis, the results from the sensitivity analyses appeared to be robust against the influence of individual studies.
Cause of 30-day all-cause readmissions after SAVR and TAVR
We found three articles reporting on causes of 30-day all-cause readmissions for SAVR patients (28, 31, 34). Heart failure (15-19%) and cardiac rhythm disorder (10-14%) were the most frequently reported causes of 30-day all-cause readmission after SAVR. Infections, lung complications/respiratory problems, and bleedings ranged from 3-14%, as causes of readmissions after SAVR (Online Table 4 ).
We found nine articles reporting on causes of 30-day all-cause readmissions after TAVR. Heart failure (up to 30%), respiratory problems (up to 14%), infections (up to 13%), and arrhythmia (up to 10%) were the most frequently reported causes of 30-day all-cause readmission after TAVR (Online Table 5 ).
Risk factors for 30-day all-cause readmissions after SAVR and TAVR
We identified six articles reporting data on risk factors for 30-day all-cause readmission after TAVR (7, 11, 37, 39, 40, 48 Table 6 .
We found no articles that comprehensively reported on risk factors for 30-day allcause readmission after SAVR.
Discussion
Reported hospital readmission rates vary substantially following SAVR and TAVR, obscuring rational guidance for clinicians, hospital administrators, and policy-makers. An accurate estimation of readmission rates and risk factors is also relevant for researchers, because reliable estimates are needed for benchmarking new valve replacement prototypes and to calculate study population sample sizes.
The meta-analysis we report here estimated a pooled 30-day all-cause readmission rate of 17% for SAVR and 16% for TAVR. The readmission rates are high, which we know are an additional burden for patients and caregivers, costly for society, and increase the risk of hospital-acquired infections and other errors (10) . Poor quality of care and transitional care
contributes to high numbers of readmissions, but some readmissions are not necessarily attributable to the quality of care (49) . Some are unavoidable and occur due to expected complications after the treatments (49) . We don't know the proportion of avoidable readmissions after SAVR and TAVR, and this makes the interpretation of readmissions as a quality indicator difficult. Greater age and higher comorbidity, and major surgery, suggest a need to examine the proportions of avoidable and unavoidable readmissions after SAVR and TAVR. Having firm data on avoidable and unavoidable readmissions would help healthcare professionals to tailor new interventions to prevent readmissions, especially avoidable ones, and to improve transitional care in order to reduce burdens associated with readmissions.
Studies on 30-day all-cause readmission rates in SAVR and TAVR populations, support the notion that the proportion of readmissions in these two groups of patients are not significantly different (28, 34), and are approximately similar to the estimates of the metaanalysis. However, because the populations differ (e.g., in age and comorbidity), one cannot obtain generalizable data by directly comparing the 30-day all-cause readmission rates between SAVR and TAVR patients (28). When the two groups of patients were matched, though, the 30-day all-cause readmission rates seem to be similar (28). Interestingly, studies have shown that TAVR done with a transapical approach (TAVR-TA) seems to produce a higher proportion of readmissions than TAVR done with a transfemoral approach (TAVR-TF) and SAVR (43) , possibly due to a higher risk profile (34) .
In the SAVR and TAVR studies we analyzed, we found a significant increase in the proportion of 30-day all-cause readmissions in multicenter studies compared to single-center studies. Cohort studies with 30-day all-cause readmission numbers retrieved from large administrative databases might capture more readmissions than single-center studies. Singlecenter studies might not capture all readmissions if patients are admitted to other hospitals outside their area (33) . Moreover, registry data can also be biased/corrupt (50). Indeed, studies depending on administrative data from a registry rarely contain detailed descriptions of how the data were validated (50). When evaluating the methodological quality of the included studies, we found that none of them provided a detailed transparent statement on the validity of the 30-day all-cause readmission numbers.
We observed regional differences among studies in the meta-analysis, with more 30- Causes of 30-day all-cause readmissions after SAVR are poorly described. In this systematic review, we found that heart failure and heart rhythm disturbances are prominent causes. This is similar to the reported causes for readmissions after cardiac surgery, in general, in addition to infections and bleeding (53) . In the TAVR population, heart failure is the most frequently reported cause of 30-day all-cause readmission. However, heart blocks are also common (35) , requiring postoperative implantations of permanent pacemakers in 10-30% of the patients (54, 55).
Examining the risk factors for 30-day all-cause readmission after TAVR showed that these patients harbor high comorbidity and an underlying frailty (11, 34). COPD, diabetes, heart failure, greater age, and being female have been reported to be predictors for 30-day allcause readmission after cardiac surgery (9, 33, 53, (56) (57) (58) (59) . Many of these predictors for readmissions are also described in the general cardiac surgery population. Risk factors for 30-day all-cause readmission after SAVR are not comprehensively described, at least for articles included in our exhaustive search.
Clinical implications
Recent evidence suggests a slight increase in mortality among heart-failure patients, simultaneously with the reduction of readmissions due to the implementation of HRRP in the USA (60) . Knowing that heart failure is a prominent cause and risk factor of readmissions after invasive cardiac procedures, such as SAVR and TAVR, this gives rise to concern for the care of these populations in the discharge and early rehabilitation phase.
Given that the population of older ones continues to increase, we expect that SAVR and TAVRs procedures also will increase in the coming years. If most readmissions after SAVR and TAVR are unavoidable, then we should tolerate a higher number of readmissions to avoid unintended consequences of focusing exclusively on avoiding readmissions. One meta-analysis showed that 27% of readmissions are considered to have been avoidable (61).
Increasing the quality of symptom monitoring in the early phase after discharge might prevent avoidable readmissions and maintain patient safety for those who must be readmitted (62) .
Research implications
The overall numbers of 30-day all-cause readmissions after SAVR and TAVR can be used to achieve more robustly powered studies. Indeed, the present meta-analysis provides reliable figures for calculating sample sizes for future intervention studies (e.g., aiming to reduce readmissions) (63) or for improving the transition of care. Furthermore, the high number of readmissions underscores a greater need for research aimed at determining the proportion of avoidable readmissions, because that type of readmission is auspicious for quality-enhancing interventions. Completing more prospective studies will ensure higher data quality and detailed follow-up. Finally, to understand and to be able to appraise the readmission statistics, transparency on how the readmission numbers are validated in research should be comprehensively reported in the publications.
Methodological considerations
The present systematic review and meta-analysis has methodological strengths. In both the SAVR and TAVR groups, there were more than 10 appropriate articles evaluated, which enabled us to perform a random effects meta-regression on study-level variables.
Furthermore, none of the included articles reported on studies that were of poor quality. The extensive search we conducted implies that we likely missed few or no relevant studies. In addition, we found no publication bias, and the sensitivity analysis shows that the results are robust and strengthens validity of the results from the meta-analysis.
However, there were also some methodological limitations of our review and analysis that warrant discussion. First, there was great heterogeneity between the studies reported on which could be caused by differences in competence among surgeons, cardiologists, intervention radiologists, etc. There were also differences in patient volumes among the hospitals, device usage, and follow-up strategies after discharge. (66) .
Conclusions
Our findings demonstrate a high proportion of 30-day all-cause readmissions after SAVR (17%) and TAVR (16%). In the SAVR group, higher readmission rates were reported in multicenter studies, the USA, retrospective studies, and studies with readmission as the primary outcome. In the TAVR group, higher readmission rates were reported in multicenter studies, the USA, and in retrospective studies. Heart failure and hearth rhythm disturbances are common causes of readmission in patients with heart valve problems. The results of the present systematic review and meta-analysis provide new impetus for conducting qualityenhancing projects and provide the necessary data for accurately calculating sample sizes for future trials. Online Online Table 3 . Quality assessment of included articles based on the Newcastle-Ottawa Scale (NOS). 
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